Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Peter

Showing results (591-600 of 674) with videos related to

Pageof 68
Sort By:
The Journal of Biological Chemistry|August 15, 2002
MADM, a novel adaptor protein that mediates phosphorylation of the 14-3-3 binding site of myeloid leukemia factor 1Raelene Lim, Louise N Winteringham, James H Williams, et al.
Bioanalysis|November 19, 2010
The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysisNatasha Savoie, Brian P Booth, Troy Bradley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxelIan C Smith, Steven D Heys, Andrew W Hutcheon, et al.
The Journal of Biological Chemistry|December 10, 2003
HLS5, a novel RBCC (ring finger, B box, coiled-coil) family member isolated from a hemopoietic lineage switch, is a candidate tumor suppressorJean-Philippe Lalonde, Raelene Lim, Evan Ingley, et al.
Cancer Research Communications|May 25, 2022
<i>In silico</i> epitope prediction analyses highlight the potential for distracting antigen immunodominance with allogeneic cancer vaccinesC Alston James, Peter Ronning, Darren Cullinan, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2017
In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admissionA Mischnik, P Baumert, A Hamprecht, et al.
The Journal of Clinical Investigation|June 27, 2017
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockadeMark Ayers, Jared Lunceford, Michael Nebozhyn, et al.
Infection|February 24, 2025
Cardiac structure and function 1.5 years after COVID-19: results from the EPILOC studyJana Schellenberg, Lynn Matits, Daniel A Bizjak, et al.
Cancer Gene Therapy|December 16, 2017
Development of an adenovirus vector vaccine platform for targeting dendritic cellsPiyush K Sharma, Igor P Dmitriev, Elena A Kashentseva, et al.
Frontiers in Psychology|April 19, 2024
Coping as a resource to allow for psychosocial adjustment in fatal disease: results from patients with amyotrophic lateral sclerosisJulia Finsel, Angela Rosenbohm, Raphael S Peter, et al.
Pageof 68

Showing results (591-600 of 674) with videos related to

Sort By:
Pageof 68
The Journal of Biological Chemistry|August 15, 2002
MADM, a novel adaptor protein that mediates phosphorylation of the 14-3-3 binding site of myeloid leukemia factor 1Raelene Lim, Louise N Winteringham, James H Williams, et al.
Bioanalysis|November 19, 2010
The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysisNatasha Savoie, Brian P Booth, Troy Bradley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxelIan C Smith, Steven D Heys, Andrew W Hutcheon, et al.
The Journal of Biological Chemistry|December 10, 2003
HLS5, a novel RBCC (ring finger, B box, coiled-coil) family member isolated from a hemopoietic lineage switch, is a candidate tumor suppressorJean-Philippe Lalonde, Raelene Lim, Evan Ingley, et al.
Cancer Research Communications|May 25, 2022
<i>In silico</i> epitope prediction analyses highlight the potential for distracting antigen immunodominance with allogeneic cancer vaccinesC Alston James, Peter Ronning, Darren Cullinan, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2017
In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admissionA Mischnik, P Baumert, A Hamprecht, et al.
The Journal of Clinical Investigation|June 27, 2017
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockadeMark Ayers, Jared Lunceford, Michael Nebozhyn, et al.
Infection|February 24, 2025
Cardiac structure and function 1.5 years after COVID-19: results from the EPILOC studyJana Schellenberg, Lynn Matits, Daniel A Bizjak, et al.
Cancer Gene Therapy|December 16, 2017
Development of an adenovirus vector vaccine platform for targeting dendritic cellsPiyush K Sharma, Igor P Dmitriev, Elena A Kashentseva, et al.
Frontiers in Psychology|April 19, 2024
Coping as a resource to allow for psychosocial adjustment in fatal disease: results from patients with amyotrophic lateral sclerosisJulia Finsel, Angela Rosenbohm, Raphael S Peter, et al.
Pageof 68